๐ฌ Prostate Cancer Biomarkers Market to Reach $12.62 Billion by 2033
The global prostate cancer biomarkers market is projected to grow from US$ 4.92 billion in 2024 to US$ 12.62 billion by 2033, registering a CAGR of 11.03% between 2025 and 2033.
Growth is driven by ri****g prostate cancer cases, advancements in molecular diagnostics, and increa****g demand for personalized medicine and non-invasive testing. Expanding research and healthcare infrastructure in emerging markets are also boosting adoption.
๐ Read the full report: https://www.renub.com/prostate....-cancer-biomarkers-m
#prostatecancer #biomarkers #dia
์ฒ๋ผ
๋
ผํ
๊ณต์ ํ๋ค
